For a man facing a prostate biopsy, an MRI scan can give doctors a clearer idea of where to look for cancer before they ...

PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men whose MRI findings are ...

For decades, the diagnosis of clinically significant prostate cancer has rested on an uncomfortable compromise.

Using prostate MRI before a biopsy is a real advance in prostate cancer diagnosis. Multiple randomized trials have shown that imaging the prostate first and then targeting suspicious lesions finds ...

There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...

A real-world clinical validation of a commercial AI system for prostate MRI found high sensitivity for clinically significant ...

Thousands of men with suspected prostate cancer could be spared invasive procedures by instead being offered a simple, painless scan, a study suggests. British researchers found MRI scans alone can, ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the United States (U.S.) Food and Drug ...